Who is sponsoring NCT03794024?

NCT03794024 is sponsored by The Cleveland Clinic.

What condition does NCT03794024 study?

NCT03794024 studies Complex Regional Pain Syndrome.

Is NCT03794024 still recruiting?

NCT03794024 is currently terminated. Last updated 27 February 2023.

Are results published for NCT03794024?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-02-27 · How we verify

NCT03794024

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Dorsal Column Stimulation to Dorsal Root Ganglion Stimulation for Complex Regional Pain Syndrome

Terminated Results posted Last updated 27 February 2023

What this trial tests

trial testing The Nuvectra Algovita Dorsal Column Spinal Cord Stimulator in Complex Regional Pain Syndrome in 1 participant. Terminated before completion.

Timeline

8 January 2019

Primary endpoint
3 March 2020

31 March 2020

Quick facts

Lead sponsor	The Cleveland Clinic
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	1
Start date	8 January 2019
Primary completion	3 March 2020
Estimated completion	31 March 2020
Sites	1 location across United States

Drugs / interventions tested

The Nuvectra Algovita Dorsal Column Spinal Cord Stimulator
The Axium Neurostimulator System

Conditions studied

Complex Regional Pain Syndrome — all drugs for Complex Regional Pain Syndrome →

Sponsor

The Cleveland Clinic

Who can join

18 and older, any sex, with Complex Regional Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Complex Regional Pain Syndrome (CRPS) is a constellation of pain symptoms which are associated with impairment in mood, social and physical function. Spinal Cord Stimulation (SCS), a technique of placing electrodes into the epidural space is a validated treatment for Complex Regional Pain Syndrome . Treatment of CRPS with SCS, in combination with physical therapy, reduced pain to a greater degree than physical therapy alone. 40%-50% of CRPS patients achieve \>50% pain relief with SCS using dorsal column stimulation . Dorsal Root Ganglion (DRG) SCS has also recently demonstrated clinical efficacy in patients with CRPS and peripheral causalgia . The hypothesis is that DRG stimulation is non-inferior to dorsal column SCS in patients with CRPS who have failed to respond to a course of analgesics and physical therapy. The aim to assess functional, quality of life, patient satisfaction and medication requirements in subjects treated with neuromodulation for CRPS and contrast outcomes amongst subjects treated with DRG SCS and dorsal column SCS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Complex Regional Pain Syndrome

Currently open trials in the same condition.

NCT06769373 — The Effects of Whirlpool and Contrast Bath in Patients with Complex Regional Pain Syndrome After Distal Radius Fracture · NA · recruiting
NCT06393101 — The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regi · Phase 1 · recruiting

Other The Cleveland Clinic trials

Trials by the same sponsor.

NCT07218198 — Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension · NA · not yet recruiting
NCT07442747 — Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS · NA · not yet recruiting
NCT07471464 — Centered Surgery - Preoperative Counseling and Patient Satisfaction · recruiting
NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
NCT07363343 — Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03794024 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Cleveland Clinic
Last refreshed: 27 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03794024.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing